The interplay between driver mutations and aneuploidy during tumorigenesis is largely unexplored. Here, the authors show two types of associations, leading to different therapeutic vulnerabilities and prognoses.
- Noam Auslander
- Yuri I. Wolf
- Eugene V. Koonin